![Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study. - Abstract - Europe PMC Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3664112/bin/nihms-374013-f0012.jpg)
Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study. - Abstract - Europe PMC
CD4 cell reconstitution is impaired in patients with toxoplasma encephalitis as an AIDS indicator disease as compared to patient
![Treatment of relapsing Mycobacterium avium infection with interferon-gamma and interleukin-2 in an HIV-negative patient with low CD4 syndrome - International Journal of Infectious Diseases Treatment of relapsing Mycobacterium avium infection with interferon-gamma and interleukin-2 in an HIV-negative patient with low CD4 syndrome - International Journal of Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1e1c5cf5-7add-40ec-a503-9cd7d5ef38e1/gr1_lrg.jpg)